Home › Companies › ABCELLERA BIOLOGICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ABCELLERA BIOLOGICS INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 1, 2026.
Meeting of June 13, 2024: 4 items on ABCELLERA BIOLOGICS INC.’s Form 8-K, filed June 13, 2024: 2 approved · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore ABCELLERA BIOLOGICS INC. in the interactive database Compare manager voting policies
These tallies are ABCELLERA BIOLOGICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Véronique Lecault, Ph.D. | 167,328,506 | 6,868,582 | 15,059,808 | -- | -- | 96% | Not verified | — |
| Elect Director: Andrew Lo, Ph.D. | 152,914,311 | 6,017,047 | 30,325,538 | -- | -- | 96% | Not verified | — |
| 2. Proposal 2 | 211,978,251 | 306,801 | 377,463 | -- | -- | 99.8% | Approved | — |
| 3. ` Proposal 3 | 176,566,724 | 7,454,852 | 5,235,320 | -- | -- | 96% | Approved | — |
Source: ABCELLERA BIOLOGICS INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.
Each item below shows how the 121 asset managers that disclosed a ABCELLERA BIOLOGICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ABCELLERA BIOLOGICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect two class I directors to our Board of Directors, to serve until the 2027 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Andrew Lo
ABCELLERA BIOLOGICS INC.’s own tally for this item (“Elect Director: Andrew Lo, Ph.D.”): 152,914,311 for, 6,017,047 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 12,473,163 for, 72,000 against, 1,188,920 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 0 | 531,175 | Withhold |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 289,836 | Withhold |
| Lazard | 0 | 0 | 0 | 147,984 | Withhold |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 107,941 | Withhold |
| American Century | 0 | 0 | 0 | 84,829 | Withhold |
| Federated Hermes | 0 | 72,000 | 0 | 0 | Against |
| State Street | 42,369 | 0 | 0 | 0 | For |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 25,000 | Withhold |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 2,034 | Withhold |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 99 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 22 | Withhold |
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect two class I directors to our Board of Directors, to serve until the 2027 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Veronique Lecault
ABCELLERA BIOLOGICS INC.’s own tally for this item (“Elect Director: Véronique Lecault, Ph.D.”): 167,328,506 for, 6,868,582 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 20 asset managers below reported 13,691,714 for, 42,369 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| Lazard | 147,984 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 107,941 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
| Federated Hermes | 72,000 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 42,369 | Withhold |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 25,000 | 0 | 0 | 0 | For |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 2,034 | 0 | 0 | 0 | For |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
| Invesco | 99 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 22 | 0 | 0 | 0 | For |
Combines 13 wordings of this item as funds reported it.
85% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 0 | 4,824,565 | 0 | 0 | Against |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| Lazard | 147,984 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 107,941 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
| Federated Hermes | 72,000 | 0 | 0 | 0 | For |
| State Street | 42,369 | 0 | 0 | 0 | For |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 25,000 | 0 | 0 | 0 | For |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 2,034 | 0 | 0 | 0 | For |
| Gabelli | 0 | 1,900 | 0 | 0 | Against |
| Invesco | 99 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 22 | 0 | 0 | 0 | For |
Fund voting reports, all 20 managers: 8,907,618 for, 4,826,465 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 26,125,640 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 7,820,505 | 0 | 0 | 0 | For |
| Capital Group | 0 | 4,824,565 | 0 | 0 | Against |
| Voya | 4,490,520 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 4,180,768 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 4,105,095 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,873,412 | 200 | 0 | 0 | For |
| UBS | 3,633,506 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 2,374,800 | 0 | 0 | Against |
| Lazard | 1,715,122 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,126,915 | 0 | 0 | 0 | For |
| NICOLA WEALTH MANAGEMENT LTD. | 1,013,580 | 0 | 0 | 0 | For |
| Two Sigma | 624,534 | 0 | 0 | 0 | For |
| Mediolanum International Funds Ltd | 0 | 555,383 | 0 | 0 | Against |
| BESSEMER INVESTMENT MANAGEMENT LLC | 531,175 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 432,563 | 0 | 0 | 0 | For |
| DE Shaw | 343,085 | 0 | 0 | 0 | For |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 250,248 | 0 | 0 | 0 | For |
| BlackRock | 229,289 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 162,000 | 0 | 0 | 0 | For |
| Allianz | 133,078 | 0 | 0 | 0 | For |
| Polar Asset Management Partners Inc. | 117,830 | 0 | 0 | 0 | For |
| Renaissance | 95,803 | 0 | 0 | 0 | For |
| STANSBERRY ASSET MANAGEMENT, LLC | 91,533 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
Institutional-manager reports, all 103 managers: 61,920,499 for, 7,757,573 against. Showing the 25 largest; see all in the interactive database.
100% of fund votes cast · no official result
The 3 asset managers below reported 9,665,032 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TD ASSET MANAGEMENT INC | 9,658,858 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 6,174 | 0 | 0 | 0 | For |
| IPConcept (Luxemburg) S.A. | 0 | 0 | 0 | 0 | -- |
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
The 17 asset managers below reported 13,179,800 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| Lazard | 147,984 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 107,941 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
| State Street | 42,369 | 0 | 0 | 0 | For |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 25,000 | 0 | 0 | 0 | For |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 2,034 | 0 | 0 | 0 | For |
| Invesco | 99 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 22 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2024.
The 3 asset managers below reported 554,283 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Federated Hermes | 72,000 | 0 | 0 | 0 | For |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 294,054,356 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Virtus | 2.09% |
| 2 | Capital Group | 1.64% |
| 3 | BAILLIE GIFFORD FUNDS | 0.28% |
| 4 | OLD WESTBURY FUNDS INC | 0.18% |
| 5 | Vanguard | 0.16% |
| 6 | Columbia Threadneedle | 0.10% |
| 7 | Lazard | 0.05% |
| 8 | OPTIMUM FUND TRUST | 0.04% |
| 9 | Listed Funds Trust | 0.04% |
| 10 | American Century | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 8.88% |
| 2 | BAILLIE GIFFORD & CO LTD | 2.66% |
| 3 | Capital Group | 1.64% |
| 4 | Voya | 1.53% |
| 5 | ORBIMED ADVISORS LLC | 1.42% |
| 6 | ArrowMark Colorado Holdings LLC | 1.40% |
| 7 | BAILLIE GIFFORD OVERSEAS LTD | 1.32% |
| 8 | UBS | 1.24% |
| 9 | Man Group plc | 0.81% |
| 10 | Lazard | 0.58% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Carl L.G. Hansen | 20.66% | 13G |
| Thermopylae Holdings Ltd. | 18.98% | DEF14A |
| Baillie Gifford & Co | 8.18% | DEF14A |
| Baker Bros. Advisors LP | 7.79% | DEF14A |
| Véronique Lecault, Ph.D. | 4.05% | DEF14A |
| Andrew Booth | 1.89% | DEF14A |
| BlackRock | 1.24% | 13F |
| Morgan Stanley | 0.95% | 13F |
| Tryn Stimart | 0.72% | DEF14A |
| Michael Hayden, MBCHB (M.D.), Ph.D. | 0.64% | DEF14A |
Percentages above are of 294,054,356 shares outstanding, as reported by ABCELLERA BIOLOGICS INC. on its Form 10-Q dated May 1, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ABCELLERA BIOLOGICS INC.’s 10-Q dated May 1, 2024. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.
At ABCELLERA BIOLOGICS INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 121 asset managers reported how they voted in their SEC Form N-PX filings, covering 248 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ABCELLERA BIOLOGICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation of the Company's named executive… — the reporting funds and managers cast 85% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
ABCELLERA BIOLOGICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.